NEW YORK, August 13, 2024 – Inc. revealed today that Zeto, Inc. ranks No. 1311 on the 2024 Inc. 5000, its annual list of the fastest-growing private companies in America. The prestigious ranking provides a data-driven look at the most...
SANTA CLARA, Calif., June 4, 2024 /PRNewswire/ -- Zeto, Inc., a privately owned medical technology company, has announced that its innovative next-generation product, named the ONE, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA). Zeto ONE is approved for...
SANTA CLARA, Calif., May 7, 2024 (Newswire.com) - Zeto, Inc., an innovative EEG brain monitoring company, is pleased to announce the distinguished members of the jury panel for its first clinical trial sponsorship program. The panel, comprising professionals from the fields of neurology...
SANTA CLARA, Calif., March 18, 2024 (Newswire.com) - Zeto, Inc., a commercial-stage medical technology company transforming EEG brain monitoring in healthcare with its innovative EEG headset and advanced cloud platform, is proud to announce its renewal of SOC 2 Type II...
SANTA CLARA, Calif., March 6, 2024 (Newswire.com) - Zeto, Inc., a commercial-stage medical technology company transforming EEG brain monitoring for healthcare with its innovative EEG headset and advanced cloud platform, today announced the appointment of Neway Redia as its new Chief Financial Officer. With...
HITRUST Risk-Based, 2-year (r2) Certification validates Zeto is committed to strong cybersecurity and protecting sensitive data. SANTA CLARA, Calif., February 26, 2024 (Newswire.com) - Zeto, Inc., a commercial-stage medical technology company transforming EEG brain monitoring in healthcare with its innovative...
SANTA CLARA, Calif., November 13, 2023 (Newswire.com) Zeto, Inc., an innovative EEG brain monitoring company, is excited to make two significant announcements as the company continues to expand the boundaries of brain monitoring. Zeto is proud to announce its inaugural participation...
Zeto has been providing value to clinical customers in hospitals and private practices for some time now. However, we have recently extended our offerings to CROs and cutting-edge researchers in the field of medical research. A. Mark Mento, director of...
Prestigious International Annual Awards Program Recognizes Standout Digital Health & Medical Technology Products and Companies SANTA CLARA, Calif., – May 22, 2023 – Zeto, Inc , a commercial-stage medical technology company transforming EEG brain monitoring for health care, today announced...
SANTA CLARA, Calif., – May 18, 2023 Zeto, Inc., an innovative EEG brain monitoring company, announced its participation in the upcoming Vision Sciences Society (VSS) annual meeting in St. Pete Beach, Florida, from May 19th to 24th. The Vision Sciences...
Greenwood, Mississippi, February 15, 2023 - Greenwood Leflore Hospital in Greenwood, MS has recently upgraded its EEG capabilities with the implementation of a modern solution. The hospital, which has always prioritized offering in-house EEG tests for its patients, has adopted...
Zeto's CEO, Aswin Gunasekar, recently sat down with Scott Pantel from LSI - Life Science Intelligence™ to discuss the future of brain monitoring and how Zeto is addressing unmet needs in neurology. Aswin highlighted Zeto's work in transforming clinical EEG for patients around...
The only zero-prep, full-montage, rapid EEG solution for clinical use now offers near real-time notification of ongoing seizures by using reliable FDA cleared seizure detection software Santa Clara, California, December 1, 2022 - Zeto, Inc., an innovative EEG brain monitoring...
Providing this end-to-end solution will make EEGs accessible to any healthcare facility in the US SANTA CLARA, Calif., August 29, 2022 (Newswire.com) - Zeto, Inc., a medical technology company, has announced its partnership with Next Gen Neuro, a continuous and routine EEG...
On August 3rd, Zeto announced the launch of its new remote routine and continuous EEG monitoring services. To provide this service, we partnered with Next Gen Neuro LLC . We asked Next Gen Neuro Co-founders CEO Leisha Osburn and COO...
This service is available in real time upon request with a 30-minute notice 24/7/365. SANTA CLARA, Calif., August 3, 2022 (Newswire.com) - Zeto, Inc., announced today that it now offers remote routine or continuous electroencephalography (EEG) monitoring services to its customers....
SANTA CLARA, Calif., May 26, 2022 (GLOBE NEWSWIRE) -- Zeto, Inc., announced today that the company is now offering its customers a remote electroencephalography (EEG) reading service. This was made possible through a partnership with a physician-led organization dedicated to providing expert,...
Today, Zeto, Inc. announced its participation in the 2022 American Academy of Neurology Annual Meeting, an event for neurologists and neuroscientists, taking place April 2-7, 2022. The AAN Annual Meeting strives to promote the highest quality patient-centered neurologic care, assert the value...
Zeto was among over 1,200 global digital health and life sciences companies competing across 16 categories of the prestigious awards program produced by the UCSF Health Hub.UCSF Health Hub is a 501c3 non-profit supported and funded by Silicon Valley's top health-related...
For the August installment of the Healthtech Leader of the Month series, we interviewed Aswin Gunasekar, founder and CEO of Zeto. Zeto is a device-driven platform for acquiring, accessing, and interpreting electroencephalograms (EEGs). An EEG is a test used to evaluate electrical activity in the brain. Zeto Offers a...
Electroencephalography (EEG) devices are incredibly helpful in diagnosing and monitoring certain brain disorders, such as epilepsy and strokes. However, they are not particularly user-friendly or convenient, with specialized technicians performing time consuming procedures, such as skin preparation, to get patients...
HealthTech Arkansas announced the five early-stage companies selected for the 2020 HealthTech Arkansas healthcare accelerator. The accelerator is supported by 11 Arkansas healthcare organizations, including Arkansas Children’s Hospital, Arkansas Heart Hospital, Arkansas Urology, Baptist Health, CHI St. Vincent, Conway Regional...
A press release states that EEG (electroencephalogram) tests are conducted to detect problems in the brain that may be associated with certain brain disorders such as seizures, tumors or strokes. A typical EEG test consists of multiple electrodes attached to...
MEMPHIS, Tenn., Aug. 4, 2020 /PRNewswire/ -- Methodist Le Bonheur Healthcare (MLH) is the first hospital system globally to participate in a landmark study using a first-of-its-kind EEG device. EEG stands for electroencephalogram. EEG tests are conducted to detect problems in the...
SANTA CLARA, Calif., March 10, 2020 /PRNewswire/ -- Zeto, Inc., a privately held medical technology company that is transforming the Electroencephalography (EEG) experience for healthcare, today announced that it has raised $7.3 million in Series A financing led by Seraph...
EEG is the gold standard for observing and characterizing neural activity, but patients are subject to lengthy and uncomfortable preparation for scans, and interpretation is subjective to the physician who reads it. Zeto has introduced a device designed for patient...
Learn about ZETO and explore a whole new world of EEG. Read case studies from Dr. Virginia Thornley and Joe Charles of JLC Services to learn more about our EEG headset's applications. Visit our FAQ page for more on Zeto's...
Zeto is a medical technology startup transforming the way EEG (Electroencephalography) is done at hospitals. They are solving a problem that has remained unsolved since EEG was invented in 1924, that is, an archaic, tedious approach that consumes time, requires...
Zeto EEG provides a better, more convenient EEG testing experience to patients and technicians and faster turnaround time to hospitals than current technology SANTA CLARA, Calif., May 29, 2018 /PRNewswire/ -- Zeto, Inc., a privately held medical technology company transforming...
Congratulations to Zeto and its CEO/Founder Aswin Gunasekar. The FDA has recently approved their product for clinical use. Zeto's "dry electrode" headset, is the first of its kind to obtain FDA approval, enables doctors to obtain EEGs quickly and conveniently...
In April 2018, the U.S. Food and Drug Administration (FDA) approved Zeto, Inc.'s "dry electrode" EEG (electroencephalogram) headset and its software platform for clinical use. The Zeto headset, called zEEG, is easy to wear and does not need any preparation....
The mission of the Epilepsy Therapy Project of the Epilepsy Foundation is to accelerate ideas into new therapies for people living with epilepsy and seizures. Zeto is developing a turnkey solution for Routine EEG tests by providing EEG to facilities...
Aswin Gunasekar, founder of Zeto Inc., presents his team's instant EEG project at the 2016 Epilepsy Foundation Shark Tank competitionntries around the world. Read case studies from Dr. Virginia Thornley and Joe Charles of JLC Services to learn more about...
The Epilepsy Foundation’s Shark Tank competition seeks to advance innovative ideas in epilepsy and seizure treatment and care. The winners will use their prize to accelerate their innovation to the next phase of development and closer to being accessible to...